Ablation index predicts outcomes of catheter ablation of focal atrial tachycardia: results of a multicenter study

Funding Acknowledgements

Type of funding sources: None.

Background

Ablation index (AI) is a radiofrequency energy lesion quality marker integrating power, contact force, and time, which was recently shown to be linked to successful catheter ablation (CA) of atrial fibrillation, atrial flutter, and premature ventricular complexes. The possible role of AI as a predictor of outcomes after CA of focal atrial tachycardia (AT) has not been explored so far.

Purpose

To evaluate the role of AI as a predictor of arrhythmia-free survival after CA of focal AT.

Methods

We retrospectively enrolled forty-five consecutive patients undergoing CA for focal AT in four referral Italian electrophysiology laboratories. Clinical and procedural information were collected. For each patient, maximum and mean (by averaging maximum AI values for each radiofrequency ablation lesion) values of AI were measured. Focal AT-free survival was the primary outcome, and was assessed with repeated Holter monitors or cardiac implantable electronic devices, when available. The Shapiro-Wilk’s test was used to check continuous variables for normality; non-normal variables were expressed as median (1st-3rd quartile), whereas categorical variables were reported as counts and percentages. The primary outcome was assessed in a time-to-event fashion, with the Kaplan-Meier method, and the role of AI as a predictor of focal AT recurrence was tested with univariable Cox proportional hazard regression. Furthermore, differences in AI values between patients experiencing a primary outcome event and patients not experiencing a primary outcome event were analyzed with the Student t test. Discrimination ability of AI was measured with area under the receiver operating characteristic curve, and the optimal AI cutoff value was identified with Youden’s index. An alpha level <0.05 was considered statistically significant, and the software RStudio (RStudio Inc., Boston, MA) was used for statistical analysis.

Results

CA was acutely effective in every patient; however, 20% (n=9) of the study population had a focal AT recurrence over a median follow-up of 288 (160-560) days. Both maximum and mean AI values were significantly higher among patients without AT recurrences (maximum AI=568±91, mean AI=426±105) than in patients with AT relapses (maximum AI=447±142, mean AI=352±76, p=0.036 and p=0.028, respectively). All other procedural parameters were similar between the two groups. In a time-to-event analysis, only maximum AI was significantly associated with survival free from AT recurrence (p=0.001, Figure), whereas mean AI was not (p=0.08). By receiver operating characteristic (ROC) curve analysis, the optimal maximum AI cutoff for predicting effective CA according to Youden’s index was 461 (sensitivity, 0.89; specificity, 0.56).

Conclusion

We observed a strong association between maximum AI and outcomes, suggesting that maximum AI may be regarded as a quantitative marker of successful CA of focal AT.

Conduction velocity mapping in Bachmann Bundle using Omnipolar Technology

Funding Acknowledgements

Type of funding sources: None.

Background

Bachmann’s bundle is emerging as a critical component of atrial fibrillation (AF) catheter ablation (CA). The introduction of Omnipolar Technology (OT) in the new Ensite X Cardiac Mapping system, provides three-dimensional information on conduction velocity, activation direction and voltage of endocardial potentials, independently of catheter orientation. OT can create a wave speed map: a color map type coded by numeric value of conduction velocity.

Objective

To assess the feasibility and reliability of left atrium wave speed maps in Bachmann’s bundle identification and conduction velocity characterization.

Methods

We included 10 patients, (60% male, 40% female, mean age 56±8.7 years) undergoing CA for paroxysmal AF at our institution with new Ensite X Cardiac Mapping System; the left atrium (LA) was mapped with the Advisor HD Grid catheter. A sinus rhythm voltage map and wave speed map were obtained and analyzed to identify high conduction velocity areas throughout the Bachmann’s bundle location (septum, roof and left atrium appendage (LAA)).

Results

Wave speed mapping allowed the identification, at the septum, roof and LAA, of a myocardial bundle with greater speed values (2.5±0.3 m/s) with respect to mean atrial value (1±0.1). Pulmonary vein antra conduction velocity mean value was 1.2±0.4 m/s. Standard voltage map (low-voltage areas defined as any LA region with voltage values < 0.5 mV) was compared with wave speed map. Standard voltage map (Figure 1) did not discriminate Bachmann’s bundle, while wave speed map did (Figure 2).

Conclusion

Wave speed mapping introduced by OT is a promising new map type, allowing characterization and identification of Bachmann’s bundle. Further studies are needed to assess the impact of this new technology on procedural workflow and clinical outcome.

High-density substrate mapping of the left ventricle as a guide for endomyocardial biopsy: an omnipolar, bipolar, and cardiac magnetic resonance imaging perspective

Funding Acknowledgements

Type of funding sources: None.

Background

The recent introduction of Omnipolar Technology (OT) has the potential to improve ventricular substrate characterization. In fact, the amplitude of omnipolar electrograms is less dependent of the propagation direction of the recorded wavefront than that of bipolar electrograms, potentially increasing the sensitivity for the detection of viable myocardium by electroanatomical voltage mapping (EVM).

Purpose

To assess the presence and extension of dense scar regions and low-voltage areas in omnipolar voltage (OV) maps of the left ventricle (LV) as compared to standard bipolar endocardial maps and cardiac magnetic resonance (CMR)-derived pixel signal intensity (PSI) maps, among patients undergoing EVM-guided endomyocardial biopsy (EMB).

Methods

The study included 10 patients undergoing LV substrate mapping and EVM-guided EMB at our institution using the Advisor HD Grid mapping catheter. Before the procedure, contrast enhanced-CMR was obtained for each patient and PSI maps were derived from late gadolinium enhancement sequences with the ADAS-VT software. Scar core and border zone areas were measured in PSI endocardial (10-40% of wall thickness) maps and compared to dense scar regions (<0.5 mV) and low-voltage areas (0.5-1.5 mV) measured by standard bipolar endocardial mapping and OV endocardial mapping, respectively. Continuous variables were checked for normality with the Shapiro-Wilk test, and are reported as mean±standard deviation or median [1st-3rd quartile], as appropriate. Statistical comparisons among the three types of mapping (PSI mapping, standard bipolar, and OV) were performed with Friedman test with post-hoc sign test, as appropriate. P values<0.05 were considered statistically significant, and all analyses were performed with the software RStudio.

Results

The indication for EVM-guided EMB was a clinical suspicion of arrhythmogenic or inflammatory cardiomyopathy in all cases. Dense scar regions and low voltage areas detected by OV (dense scar: 2.2 [1.2-6.9] cm2; low voltage areas: 8±3.8 cm2) and standard bipolar mapping (dense scar: 3.4 [2.3-9.6] cm2; low voltage areas: 8.4±4 cm2) were similar to scar core and border zone areas shown by PSI maps (scar core: 1.6[0.6-2.9] cm2; border zone: 3.9[3.7-7.6] cm2; all p=NS). However, dense scar regions were less widespread with OV mapping that with standard bipolar mapping (Friedman test p=0.07; adjusted p=0.006, Figure). The diagnostic yield of EMB measured 80%, whereas mean procedural and fluoroscopy times were 136±30 min and 11±4 min, respectively.

Conclusion

OV mapping allowed a refinement of endocardial substrate maps of the LV as compared to standard bipolar mapping, by reducing the dependency of electrogram amplitude on the direction of propagation, thus allowing the detection of viable myocardium even in bipolar scar regions. Therefore, OV mapping may soon become a preferred approach for EVM-guided EMB.

Role of an extensive diagnostic work-up in the detection of concealed cardiomyopathies in athletes with premature ventricular complexes and implications for sports' eligibility assessment

Background

Premature ventricular complexes (PVCs) are a common clinical problem and a critical issue with regard to sports eligibility in sportsmen. Although PVCs can be considered a benign feature of the athlete's heart adaptive phenotype, they may also be the only clinical manifestation of a concealed cardiomyopathy, potentially heralding sudden cardiac death (SCD) during sports activity. The optimal diagnostic evaluation of athletes with PVCs is currently uncertain.

Purpose

To evaluate the diagnostic contribution and the implications for sports eligibility assessment of a thorough non-invasive and invasive work-up including electroanatomical mapping (EAM) and endomyocardial biopsy (EMB) in athletes with PVCs.

Methods

We conducted a prospective, single-arm, open-label double center study. All consecutive athletes presenting for evaluation at our institution after being disqualified from participating in sports due to PVCs were included in our study. These athletes underwent a baseline non-invasive diagnostic protocol with transthoracic echocardiogram and gadolinium enhanced cardiac magnetic resonance imaging (cMRI). Subsequently, an invasive diagnostic work-up was performed, including EPS with programmed electrical stimulation, EAM and EAM-guided EMB if deemed necessary. When clinically indicated, catheter ablation was performed. Sports eligibility status was re-assessed at six months' follow-up according to Italian sports medicine guidelines.

Results

After diagnostic evaluation, 20 subjects out of 107 (19%) had a diagnosis of heart disease, most commonly myocarditis (n=8), arrhythmogenic right ventricular cardiomyopathy (ARVC, n=7) or dilated cardiomyopathy (DCM, n=2). On multivariate logistic-regression analysis, QRS complex/T wave abnormalities on ECG (OR 23), non left bundle branch block and inferior axis PVC morphology (OR 13), echocardiogram abnormalities (OR 24) and low-voltage areas on EAM (OR 33) were significantly associated with diagnosis of a concealed cardiac disease. Nondiagnostic abnormalities on cMRI were common in this population of athletes, prevalently involving the right ventricle. EAM-guided EMB was performed in 12 subjects (11%) and catheter ablation in 56 (52.3%). After six months, 63 athletes (59%) were judged eligible to participate in competitive sports and 23 subjects (21%) were deemed eligible to participate in non-competitive sports.

Conclusions

Almost one fifth of sportsmen presenting with PVCs have a concealed heart disease, most commonly myocarditis or ARVC. Non-outflow tract PVCs' morphology and abnormalities on ECG, echocardiogram and EAM are predictive of structural heart disease's detection, whereas nondiagnostic findings on cMRI can be misleading in athletes. Invasive diagnostic tests, including EAM and EAM-guided EMB, play a critical role in case of diagnostic uncertainty. More than ¾ of subjects were judged eligible to participate in sports at 6 months' follow-up.

Funding Acknowledgement

Type of funding source: None

P1110Role of an extensive diagnostic work-up in the detection of concealed cardiomyopathies in athletes with complex ventricular arrhythmias and implications for sports" eligibility assessment

Background

ventricular Arrhythmias (VAs) are a common clinical problem and a critical issue with regards to sports" eligibility in athletes. Although VAs can be considered a benign feature of the athlete’s heart adaptive phenotype, they may also be the only clinical manifestation of a concealed cardiomyopathy, potentially heralding sudden cardiac death (SCD) during sports activity.

Purpose

to evaluate the diagnostic contribution and the implications for sports eligibility assessment of a thorough non-invasive and invasive work-up including electrophysiology study (EPS), electroanatomical mapping (EAM) and endomyocardial biopsy (EMB) in athletes with complex VAs and to derive a multiparametric risk score in order to easily predict structural heart diseases’ diagnosis.

Methods

we conducted a prospective, single-arm, open-label single center, observational study. All consecutive athletes presenting for evaluation at our institution after being disqualified from participating in sports due to complex VAs were enrolled. The athletes underwent a baseline non-invasive diagnostic protocol with transthoracic echocardiogram and gadolinium enhanced cardiac magnetic resonance imaging (cMRI). Subsequently EPS, EAM and EAM-guided EMB were performed if deemed necessary. Sports eligibility status was re-assessed at 6 months’ follow-up. A multivariable logistic regression model was built, considering cMRI as the gold standard exam.

Results

after diagnostic evaluation, 55 subjects (26.4%) had a diagnosis of heart disease, most commonly myocarditis (n = 27) and arrhythmogenic right ventricular cardiomyopathy (ARVC, n = 16). After 6 months, 100 athletes (48.1%) were judged eligible to participate in competitive sports and 46 subjects (22.1%) were deemed eligible to participate in non-competitive sports. On multivariable logistic-regression analysis, abnormalities on ECG (OR 5.3) or on echocardiogram (OR 3.7), sustained VA inducibility on EPS (OR 17.7) and low-voltage areas on EAM (OR 7.7) proved all predictive of concealed structural heart diseases’ diagnosis. We derived two simple risk scores: a 40-points risk score and an 8-points risk score (obtained by weighing each variable according to the regression model’s ORs). Both these risk scores’ performance proved very good (AUC = 0.856 for the 40-points score and AUC = 0.852 for the 8-points score, figure 1).

Conclusions

approximately 1/4 of athletes presenting with complex VAs have a concealed heart disease, most commonly myocarditis or ARVC. ECG, echocardiogram and EAM abnormalities and sustained VAs inducibility on EPS are predictive of structural heart diseases’ detection. Therefore, these diagnostic tests should be routinely included in the evaluation of athletes with complex VAs. A risk score including the results of these tests can greatly help in the prediction of concealed structural heart diseases’ diagnosis. More than 2/3 of subjects were judged eligible to participate in sports at 6 months’ follow-up.

Abstract Figure 1. ROC curves for diagnosis

Use of enzymes in the production of semi-synthetic penicillins and cephalosporins: drawbacks and perspectives

Semi-synthetic β-lactamic antibiotics are the most used anti-bacteria agents, produced in hundreds tons/year scale. It may be assumed that this situation will even increase during the next years, with new β-lactamic antibiotics under development. They are usually produced by the hydrolysis of natural antibiotics (penicillin G or cephalosporin C) and the further amidation of natural or modified antibiotic nuclei with different carboxylic acyl donor chains. Due to the contaminant reagents used in conventional chemical route, as well as the high energetic consumption, biocatalytic approaches have been studied for both steps in the production of these very interesting medicaments during the last decades. Recent successes in some of these methodologies may produce some significant advances in the antibiotics industry. In fact, the hydrolysis of penicillin G to produce 6-APA catalyzed by penicillin G acylase is one of the most successful historical examples of the enzymatic biocatalysis, and much effort has been devoted to find enzymatic routes to hydrolyze cephalosporin C. Initially this could be accomplished in a quite complex system, using a two enzyme system (D-amino acid oxidase plus glutaryl acylase), but very recently an efficient cephalosporin acylase has been designed by genetic tools. Other strategies, including metabolic engineering to produce other antibiotic nuclei, have been also reported. Regarding the amidation step, much effort has been devoted to the improvement of penicillin acylases for these reactions since 1960. New reaction strategies, continuous product extraction or new penicillin acylases with better properties have proven to be the key to have competitive biocatalytic processes. In this review, a critical discussion of these very interesting advances in the application of enzymes for the industrial synthesis of semi-synthetic antibiotics will be presented.

Natural Remedies and Nutraceuticals Used in Ethnoveterinary Practices in Inland Southern Italy

Traditional animal health practices are today only rarely used in Europe, as many natural remedies applied for the treatment of animals have been replaced by modern pharmaceuticals. Modern institutionalized veterinary services tend to cover every aspect of animal health care, and influence most of the veterinary practices carried out by shepherds and farmers. However, in some areas, particularly of the Mediterranean, such traditional practices persist. Few ethnoveterinary studies have been conducted in the Mediterranean. In this survey, we analysed the natural remedies that are still in use or were used until very recently to treat animals in central Lucania (inland southern Italy). Plants constitute the mainstay of the folk-veterinary regimen (about 40 preparations), but there are also a few animal- and mineral-derived preparations. Among them, the veterinary use of Cistus incanus, Colutea arborescens, Daphne laureola, and Erigeron acer is reported for the first time. Moreover, the study identified diverse traditional plant nutraceuticals used to improve animal health, as well as the quality of milk and dairy products. An important potential output of this study may be the development of eco-sustainable integrated projects focused on the maintenance of traditional animal breeding and healthcare systems. Pharmacological and toxicological considerations relating to possible applications of the recorded traditional knowledge in modern evidence-based veterinary medicine are also discussed.

Lung retransplantation 3 yrs after heart-lung transplantation

The main long-term complication after lung transplantation is chronic rejection in terms of obliterative bronchiolitis; when therapy does not arrest the progression of the airflow obstruction, lung retransplantation seems to be. at present, the only strategy in the management of chronic rejection. We report the 12 month follow-up of a single lung retransplantation in a 21 yr old female who had received a heart-lung transplantation 35 months previously for Eisenmenger syndrome. The patient had excellent first allograft function and quality of life for 26 months, then progressively deteriorated due to the occurrence of obliterative bronchiolitis, and further worsened in the following 9 months. At that time, she underwent left lung retransplantation, based on her negative history of infection, low rate of acute rejection, ambulatory status, and young age. She is now doing well at 12 months after retransplantation and her forced expiratory volume in one second is still improving, p thus justifying both retransplantation and hopeful expectation.

Lung transplantation: the experience of the Thoracic Organ Transplantation Centre of Pavia

Between January 1991 and September 1995 at the Thoracic Organ Transplantation Centre of Pavia, 193 patients entered the waiting list for heart-lung or lung transplantation. Indications for heart-lung transplantation (HLT) were mainly primary or secondary pulmonary vascular diseases. Parenchymal lung diseases were the most frequent reasons for single- (SLT) or double-lung (DLT) transplantation. During the same period, 21 patients underwent HLT, 16 SLT and 14 DLT. Early deaths (within 30 days of surgery) occurred in 2 (10%) HLT, in 3 (19%) SLT, and in 3 (21%) DLT. Nineteen (90%) patients with HLT, 11 (69%) with SLT, and 10 (71%) with DLT survived up to 3 months; and 11 (52%) patients with HLT, 8 (50%) with SLT, and 5 (36%) with DLT survived up to 12 months. At the time of writing, the following patients are still alive: 10 (48%) with HLT, after a mean +/- SEM follow-up of 37.2 +/- 6 (range 28-46) months, 12 (75%) with SLT, after a mean follow-up of 16 +/- 11 (range 1-35) months, and finally 7 (50%) with DLT, after mean follow-up of 14 +/- 9 (range 1-23) months.

[Lung transplantation in Pavia. Clinical experience]

Single and bilateral lung transplantation represents the most recent success in the field of organ replacement. The procedure underwent a very long period of laboratory and clinical experimentation and it is still a high-risk procedure to be performed by a few highly specialized centers. At our Department of Cardiac Surgery, the preliminary experience in lung replacement was obtained by clinically applying heart-lung transplantation in patients with both vascular and parenchymal lung disease during 1991. In the following years, the indications for isolated lung transplantation were enlarged by some centers with good results; this consideration, together with the scarce availability of integral heart-lung blocks, led us to use single and bilateral lung transplantation initially for parenchymal disease and subsequently also for vascular disease. Since February 1992, 12 single lung transplantations and 12 bilateral lung transplantations have been performed at our Center. In this report the selection criteria, the preoperative characteristics and the perioperative variables of donors and recipients are discussed. Particular emphasis is given to immunosuppression treatment, diagnosis of rejection and airways suture complications. The conclusions summarize the present indications for the different types of lung transplantations according to the different preoperative diagnosis.

Surveillance transbronchial biopsy in the diagnosis of acute lung rejection in heart and lung and lung transplant recipients

From March 1991 to December 1993, 30 patients underwent transbronchial biopsy (TBB) after lung transplantation (16 with a heart lung transplant, 7 with a single lung transplant, and 7 with a double lung transplant). The now standard TBB technique was used. Initially, TBB was performed only when clinically indicated, i.e. when there were sound reasons to suspect the existence of acute rejection (AR) or pulmonary infection. From 1992, all the patients were entered into a prospective study, the protocol of which called for serial "surveillance" TBB to be performed, in addition to those for clinical indications, 15 days, 2, 3, 6, 9 and 12 months after the transplant, and then annually. One hundred and twenty nine transbronchial biopsies were performed in 2.5 yrs. Of the 121 successful TBBs, 54 (45%) were positive, i.e. showed signs of acute rejection. Sixty six of 129 (51%) of the TBBs were performed because of clinical indications, 45 of them (68%) within the first 3 months following the transplant. The other 63 were surveillance biopsies. About two thirds of the clinically indicated TBBs and more than a quarter of the surveillance TBBs, yielding adequate samples, were positive for AR > or = A2 (mild rejection). The sensitivity and specificity of the method in detecting AR were 91 and 100%, respectively. The overall incidence of complications was 10.8% (pneumothorax in 9% of cases). There were no deaths correlated to the procedure. Our results confirm the decisive role of TBB in the diagnosis of acute lung rejection. The high incidence of mild acute rejection, and the occasional finding of moderate acute rejection in stable asymptomatic patients, support the use of surveillance TBB in the first 6 months.

[Not Available]

Rhodococcus equi is a facultative intracellular, obligate aerobe, partially acid fast, gram-positive pathogen that causes cavitary pneumonia in animals and immunocompromised humans. We describe 8 cases of R. equi pneumonia in patients with advanced HIV infection (CD4 counts less than 100/mm3), 7 males and 1 female (mean age 30.8 years), observed between 1991 and 1994. A history of exposure to farm animals was found in 4 patients. The most common presenting symptoms were fever, malaise, dyspnea, cough and hemoptysis, chest pain and weight loss. Chest x-rays showed tipical focal area of consolidation throughout the lung (3 upper, 3 lower and 2 middle fields) associated with cavitation in 4 cases. The definitive diagnosis in our hands was delayed only in the first case in which conflicting data resulted from blood culture (Bacillus sp. isolation) and sputum examen (acid-fast bacterium in the Ziehl-Neelsen stain). Final microbiological diagnosis depended on blood cultures (n=5), bronchoalveolar lavage (n=1), sputum (n=1), lung biopsy (n=1). All the patients were treated with prolonged courses of antibiotic therapy (259 days, range 120-340 in 6 dead patients; more than one year and two months respectively in two patients alive). According to microbial susceptibility TMP/SMX, vancomycin, imipenem, rifampin, aminoglycosides, macrolides and quinolons were more frequently used. Resistant R. equi mutants were selected during therapy with TMP/SMX (n=2), rifampin (n=1) and erythromycin (n=1). Five patient underwent pulmonary lobectomy after exclusion of metastatic bacterial lesions. Only 2 patients are alive, one after 365 days of antibiotic therapy and upper lung lobectomy, one after 60 days of antibiotic therapy. Optimal antimicrobial therapy and the role of surgery remain, in our experience, uncertain.

Coexpression of aspartic proteinases and human leukocyte antigen-DR in human transplanted lung

Aspartic proteinases have recently been shown to be implicated in antigen processing. We explored the expression of two aspartic proteinases, cathepsins E and D, and of human leukocyte antigen-DR (HLA-DR) molecules in a consecutive series of 80 transbronchial biopsies from transplanted lungs. For controls, we studied five normal donor lungs (not suitable for transplantation on account of thoracic trauma) and macroscopically normal areas of three cancer-affected lungs. Two of the five unsuitable donor lungs showed minimal inflammatory changes. Macroscopically normal samples from the three cancerous lungs showed mild and focal inflammatory infiltrates. In histologically normal lungs, HLA-DR expression was limited to professional antigen-presenting cells. Macroscopically normal lung samples with minimal inflammatory changes from both donor and cancer lungs showed variable HLA-DR expression by alveolar and bronchial epithelial cells and by endothelial cells. All transplanted lung biopsies showed HLA-DR expression by epithelial (alveolar and bronchial) and endothelial cells, with a trend for increased positivity in acute rejection. Cathepsin E was restricted to Clara and to rare bronchus-associated lymphoid tissue-related epithelial cells in histologically normal lung samples, whereas minimal de novo cathepsin E expression by rare alveolar pneumocytes was noted in control lung samples exhibiting minimal inflammatory changes. In all transplanted lung biopsies, cathepsin E was diffusely expressed de novo by hyperplastic alveolar epithelial cells, regardless of the presence or degree of rejection. Cathepsin D was expressed only by alveolar macrophages and by ciliated bronchial cells of normal, minimally inflamed, and transplanted lungs. In transplanted lung, Clara cells and several hyperplastic alveolar pneumocytes coexpressed HLA-DR and cathepsin E, whereas all alveolar macrophages and a few ciliated cells coexpressed cathepsin D and HLA-DR. The present investigation suggests that the de novo expression of cathepsin E and HLA-DR by hyperplastic alveolar pneumocytes of transplanted lung may be crucial for antigen processing and presentation to recipient competent T cells, and thus for the triggering of the immune-inflammatory cascade that leads to rejection.

K-ras gene mutations: an unfavorable prognostic marker in stage I lung adenocarcinoma

Activation of K-ras gene by point mutations, a common finding in lung adenocarcinomas, has been suggested to decrease patient survival. We investigated 109 lung adenocarcinomas, mostly small, peripheral, stage I tumours (81/109) for presence of K-ras gene mutations at codons 12 and 13. Mutations were detected by denaturing gradient gel electrophoresis analysis of specific sequences amplified by polymerase chain reaction from DNA extracted from archival pathological material. Thirty-three of 109 (30.3%) tumours showed mutations at codon 12 (28/33, 84.8%) or 13 (5/33, 15.2%) of the gene. Mutations and type of nucleotide substitutions were differently distributed among cytological subtypes, being more prevalent among less differentiated (G2 and G3) tumours and among bronchial than bronchiolo-alveolar type adenocarcinomas. Survival analysis showed an adverse effect of K-ras mutation on survival, restricted to stage I tumours. Median survival for 81 stage I patients was 30 months for non-mutated tumours versus 20 months for mutated tumours (p = 0.016). Multivariate analysis showed that age of patient (p = 0.001) and K-ras mutation status (p = 0.04) were the only independent factors influencing survival significantly. These data strengthen the hypothesis that K-ras gene mutations may be useful in identifying a subgroup of patients with poor outcome.

[The use of the expanded PTFE (Gore-Tex) prosthesis with progressive preoperative pneumoperitoneum in the repair of massive inguinal hernias and large laparoceles]

The authors present two cases of massive inguinal hernia and large recurring abdominal wall defect, in which hernia repair and wall reconstruction is made possible thanks to the use of large patches of expanded PTFE (Gore-Tex). The authors moreover insist on the efficacy of using the progressive preoperative pneumoperitoneum as a technic to prepare the patient to surgery together with respiratory physiotherapy, for the purpose of preventing the occurrence of unfavourable repercussions falling upon the cardiorespiratory apparatus with the repositioning into the abdomen of the hernias.

Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Immunohistochemical and morphological relationships to Hodgkin's disease

In this report we analyze the morphological and immunohistochemical findings observed in 5 cases of CD30/Ki-1 positive anaplastic large cell lymphoma, a recently recognized neoplastic entity. In comparison with the Ki-1 lymphomas so far described, these cases showed a fairly large number of Reed-Sternberg-like cells, often admixed with small lymphocytes and occasional eosinophils. Moreover, in all our cases immunohistochemical reactions detected the CD15/Leu-M1 antigen, together with markers of the T-lineage and of lymphoid activation. In previous studies the CD15/Leu-M1 antigen has been found in the majority of cases of Hodgkin's disease, but has been stated to be absent typically in Ki-1 lymphomas. Our results indicate that this antigen cannot be considered a reliable tool to distinguish between Ki-1 lymphomas and Hodgkin's disease. Furthermore, the morphological and immunohistochemical findings reported suggest that in some cases Ki-1 cell lymphoma and Hodgkin's disease may be closely related. They may represent different steps in the progression of the same lymphoproliferative disorder.

Intracardiac extension of lung cancer via pulmonary veins: CT diagnosis

Two cases of lung tumor in the left upper with neoplastic thrombus in the pulmonary veins and extension into the left atrium are reported. The diagnosis was made preoperatively with CT.

[Clinical definition of asymptomatic abdominal masses]

Five patients with asymptomatic abdominal masses (abdominal leiomyosarcoma, giant hydronephrosis, renal cell carcinoma, squamous cell carcinoma of the lung metastatic to the adrenal gland, retroperitoneal non-Hodgkin's lymphoma) are reported. Non invasive investigations such as Echography and Computed Tomography, are very advantageous for the quick diagnosis of asymptomatic abdominal masses and for subsequent therapy.

[Carcinoma of the common bile duct]

The clinical courses of 18 patients with extrahepatic bile duct carcinoma operated on between 1960 and 1979 are reviewed retrospectively. The preoperative and intraoperative diagnostic difficulties due to marked peritumor sclerosis are pointed out. The location of the lesion appeared to bear the most important relationship to prognosis: the lesions located in the upper and middle thirds of the extrahepatic biliary system are often invasive of adjacent vascular structures and, hence, unresectable, necessitating a proximal biliary-enteric anastomosis or intubation to alleviate jaundice and pruritus. A more aggressive operative approach, however, will result in a higher survival rate, as shown in personal experience for lower third lesions resected by Whipple's procedure.

[Comparative analysis of manual and mechanical sutures in the surgery of neoplasms of the esophagus and the cardia]

The authors analyse 50 sutures by hand and 50 by stapling device in oesophagocardial surgery, and compare them as to time of performance, number and quality of complications and influence on the protraction of stay in hospital after operation. The conclusions indicate the sutures by device as the most reliable and safe, susceptible to supplant, although not totally, the techniques by hand.

[The surgical consequences of topographical variations of the implantation of the papilla in the duodenum]

The Authors underline the importance of anatomical variations concerning the location of the duodenal papilla. In roughly 75% of cases this structure pierces the duodenal mucosa at D2 and at the level of the lower flexure, in 20% at D3 and in about 6% at D1. Intraoperative cholangiography is most useful to spot the papilla, its position is fundamental from an anatomo-surgical point of view both when this structure is placed at a high level (when performing a gastro-duodenal resection), and when located at D3 level, if sphincterotomy is required. In this latter case the usual incision at 12 hours should be carried out at 9 hours instead in order to avoid surgical damage to the canal of Wirsung running vertically and along the common bile duct.

[Our experience in the preservation of the rectum in the surgical treatment of ulcerative rectocolitis]

The Authors report a personal series of 42 cases of Ulcerative colitis seen over a 12 year period. (1969-1980). These patients underwent total colectomy with preservation of the rectum. Intestinal canalization was restored by means of an ileo-rectal anastomosis performed either with colectomy or at a later stage. Results are satisfactory as an improvement of general conditions occurred. Normalization of the intestinal function was observed in 85% of cases. Rectal lesions, periodically kept under control with endoscopy and hystologic examination, improved noticeably. In a few cases a total recovery was attained with an adequate, postsurgical, topic therapy. No cancer onset in the rectal stump had been recorded thus far among these patients. In the light of the Author's experience, total colectomy with rectal preservation represents a sensible solution for the surgical treatment of Ulcerative colitis.

[A rare case of esophageal pathology: leiomyosarcoma (author's transl)]

The AA. report a clinical case of rare oesophageal pathology: the leioomyosarcoma sole case on 200 oesophageal neoplasms that they have observed. The clinical likeness with oesophageal carcinoma and the complete superimposition of reports that have been obtained in this case with instrumental examinations respect to the oesophageal carcinoma, didn't permit to do the diagnosis of histotype, while this diagnosis could be done only after the preparation of an histopathologic preparation. The patient who was operated on for superior polar esophago-gastrectomy, after 18 months is in good general conditions. THe AA. draw their conclusions after a short discussion. We must show in these paragraphs the particular macroscopic form of neoplasm that they have observed and the great difficulty of a diagnosis of leimyosarcoma without an histopathologic preparation. Agreeing with the most part of other Authors, they point out that the best therapy for these forms is surgical therapy.

[Etiopathogenetic, diagnostic and clinical considerations on simultaneous bilateral carcinomas of the breast. I]

The Authors extensively describe five cases of bilateral simultaneous breast cancer that they observed in their Institute. They treated them surgically by the Halsted method. In next second note, the Authors discuss about the present pathogenic problems, the symptomatology and the surgical treatment.

[Etiopathogenetic, diagnostic and clinical considerations on simultaneous bilateral carcinomas of the breast. II]

In the first note the Authors have described five cases of bilateral simultaneous breast carcinoma. Now they shortly describe some opinions about the problems of the genetic independence between the two diseases. They draw attention about the histologic diagnosis and the identification of diseases underestimated and now explained as carcinoma "in situ" potentially fit for transformation in infiltrating cancer. For this reason it's important and justifiable to have the patients with cancer of the breast, a series of clinical research as well as mammography thermography and biopsy of controlateral breast in order to ascertain the presence of carcinoma "in situ" that could justify the prophylactic mastectomy.

[Association of idiopathic megaesophagus and carcinoma]

In the light of three cases of esophageal carcinoma developing on a pre-existing idiopathic megaesophagus the authors examine etiopatological, clinical and terapeutic problems related to this association. They believe that carcinoma of the esophagus tends to be a complication of cardiospasm in patients inadequately treated for the primary condition. Early diagnosis and an adequate Heller operation for cardiospasm will lessen the chance of cancer developing in megaesophagus with stasis. When finally diagnosed, this variety of esophageal carcinoma has an extremely poor prognosis. An even more important claim upon the clinician is to be alert to the hazards of continued stasis in megaesophagus and to devise earlier techniques of recognition, including more frequent recourse to biopsy during esophagoscopy.